{"id":"W4399367500","doi":"10.1080/10428194.2024.2346733","title":"Safety and efficacy of fedratinib in patients with myelofibrosis previously treated with ruxolitinib: primary analysis of FREEDOM trial","year":2024,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"Agence Nationale de la Recherche","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Clinical endpoint; Adverse effect; Internal medicine; Confidence interval; Randomized controlled trial; Population; Anemia; Phases of clinical research; Clinical trial; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001819839,0.0004396214,0.001069033,0.0001888875,0.0002687095,0.0006471808,0.0002609939,0.0005145817,0.00239552],"category_scores_gemma":[0.001300973,0.0001475557,0.001157449,0.0002197486,0.0003106715,0.000413402,0.0002526512,0.001206722,0.000358201],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004529523,"about_ca_system_score_gemma":0.0007660865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004722438,"about_ca_topic_score_gemma":0.001603504,"domain_scores_codex":[0.9995946,0.0002059219,0.00003065991,0.00006218941,0.00003722885,0.00006942912],"domain_scores_gemma":[0.999314,0.0001516588,0.0001769034,0.00006549149,0.00005304097,0.0002389806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8447836,0.006401993,0.02797002,0.0006115084,0.001613799,0.0002071638,0.0001256662,0.00141682,0.008701323,0.0003581737,0.004524444,0.1032855],"study_design_scores_gemma":[0.5342641,0.2899333,0.1486204,0.0002529212,0.002509591,0.001064736,0.0001033343,0.00407423,0.005948133,0.0008955326,0.01225167,0.00008191192],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986892,0.005069887,0.0004613084,0.0005714288,0.0001051944,0.00097206,0.002521971,0.00006417125,0.003341968],"genre_scores_gemma":[0.9944075,0.0007573036,0.0005449732,0.0003093391,0.0001212297,0.0004087501,0.002696772,0.000006503511,0.0007475383],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00239552,"threshold_uncertainty_score":0.009624302,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006397220163147106,"score_gpt":0.2262004265987101,"score_spread":0.219803206435563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}